CP

Chaudhary Preetam Singh

Active Director Director DIN 11204446
DIN 11204446 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chaudhary Preetam Singh

Data last updated:

Chaudhary Preetam Singh is a Director at Cgv Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11204446
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cgv Pharmaceuticals Private Limited U46497DL2025PTC451863
Director21 Jul 20252025Active

Board colleagues of Chaudhary Preetam Singh

NameDINCompanyDesignation
Jyotsna Singh11204447Cgv Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cgv Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chaudhary Preetam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaudhary Preetam Singh

Chaudhary Preetam Singh currently holds 1 directorship: Cgv Pharmaceuticals Private Limited (Director, since 21 Jul 2025).

Chaudhary Preetam Singh was first appointed on 21 Jul 2025 as Director at Cgv Pharmaceuticals Private Limited.

The current boards of Chaudhary Preetam Singh's companies include Jyotsna Singh (Cgv Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available